Baxter to divest biopharma solutions business to Advent International and Warburg Pincus for $4.25…
Net proceeds planned to be redeployed for debt repayment in accordance with Baxter’s stated capital allocation priorities
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.